Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXU-001 vs Ozurdex in Diabetic Macular Edema
NCT05697809Phase 2Completed
- Sponsor
- Oxular Limited
- Start
- Aug 2023
- Primary completion
- Dec 2024
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of OXU-001 in diabetic macular edema (DME), sponsored by Oxular Limited. Started Aug 2023; status: completed.
02
Drugs
OXU-001
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05697809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05697809.